# Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM

> **NCT01526694** · PHASE2 · COMPLETED · sponsor: **Azienda Ospedaliera di Bolzano** · enrollment: 30 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Bendamustine
- **DRUG:** Thalidomide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01526694
- **Lead sponsor:** Azienda Ospedaliera di Bolzano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-12
- **Final completion:** 2017-04-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01526694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01526694, "Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01526694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*